A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant Acinetobacter baumannii (CRAB) Isolates

An increasing number of untreatable infections are recorded every year. Many studies have focused their efforts on developing new β-lactamase inhibitors to treat multi-drug resistant (MDR) isolates. In the present study, sulbactam/avibactam and sulbactam/relebactam combination were tested against 18...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasteran, Fernando, Cedano, Jose, Baez, Michelle, Albornoz, Ezequiel, Rapoport, Melina, Osteria, Jose, Montaña, Sabrina, Le, Casin, Ra, Grace, Bonomo, Robert A., Tolmasky, Marcelo E., Adams, Mark, Corso, Alejandra, Ramirez, Maria Soledad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152955/
https://www.ncbi.nlm.nih.gov/pubmed/34068158
http://dx.doi.org/10.3390/antibiotics10050577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152955/
https://www.ncbi.nlm.nih.gov/pubmed/34068158
http://dx.doi.org/10.3390/antibiotics10050577

Ejemplares similares